Inhaled Product Characterization - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Inhaled Product Characterization
The authors discuss the analysis of the resulting data, focusing on methods for the calculation of mass median ærodynamic diameter, one of the metrics routinely used for comparative testing.

Pharmaceutical Technology
pp. s33-s37


1. Stimuli to the Revision Process, "Generalized Simplified Approaches for Mass Median Aerodynamic Determination," Pharmacopeial Forum 36 (3) (2010).

2. M. Copley and J. McDonald, Inhalation 3 (11), 14–17 (2009)

3. W.C. Hinds, Aerosol Technology, Properties, Behavior, and Measurement of Airborne Particles (John Wiley & Sons, 2nd ed., 1999).

4. T.K. Church et al., Proc. Respiratory Drug Deliv. XII, 2, 509–509–512 (2010).

5. D.J. Finney, Probit Analysis (Cambridge University Press, Cambridge, 1971).

6. USP 34–NF 29, Physical Tests and Determinations <601> "Aerosols, Nasal Sprays, Metered-dose Inhalers, and Dry Powder Inhalers," pp. 237–239.

7. D. Lewis, Inhalation (August 2008).

8. Inhalation Report, "How do you calculate MMAD," (2010),, accessed 10 Oct. 2011.

9. Tougas et al., AAPS Pharm. Sci. Technol., 10 (4) 1276–1285 (2009)

10. Proceedings of EPAG AIM Workshop at DDL 21 (Edinburgh International Conference Center, Dec. 8–10, 2010).

11. P.N. Pantelides et al., proceedings of RDD Europe (Berlin, 2011), pp. 391–395.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here